These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 33766529)

  • 21. Comparison of anatomic and non-anatomic hepatic resection for hepatocellular carcinoma.
    Kaibori M; Kon M; Kitawaki T; Kawaura T; Hasegawa K; Kokudo N; Ariizumi S; Beppu T; Ishizu H; Kubo S; Kamiyama T; Takamura H; Kobayashi T; Kim DS; Wang HJ; Kim JM; Han DH; Park SJ; Kang KJ; Hwang S; Roh Y; You YK; Joh JW; Yamamoto M
    J Hepatobiliary Pancreat Sci; 2017 Nov; 24(11):616-626. PubMed ID: 28887834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical factors that affect the outcomes after anatomical versus non-anatomical resection for hepatocellular carcinoma.
    Yamamoto T; Yagi S; Uryuhara K; Kaihara S; Hosotani R
    Surg Today; 2017 Feb; 47(2):193-201. PubMed ID: 27502598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of a novel risk classification of microvascular invasion in patients with hepatocellular carcinoma after resection.
    Zhao H; Chen C; Fu X; Yan X; Jia W; Mao L; Jin H; Qiu Y
    Oncotarget; 2017 Jan; 8(3):5474-5486. PubMed ID: 27729623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of postoperative adjuvant transcatheter arterial chemoembolization in hepatocellular carcinoma patients with microvascular invasion.
    Ye JZ; Chen JZ; Li ZH; Bai T; Chen J; Zhu SL; Li LQ; Wu FX
    World J Gastroenterol; 2017 Nov; 23(41):7415-7424. PubMed ID: 29151695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of resection margin and microvascular invasion on long-term prognosis after curative resection of hepatocellular carcinoma: a multi-institutional study.
    Han J; Li ZL; Xing H; Wu H; Zhu P; Lau WY; Zhou YH; Gu WM; Wang H; Chen TH; Zeng YY; Wu MC; Shen F; Yang T
    HPB (Oxford); 2019 Aug; 21(8):962-971. PubMed ID: 30718183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety.
    Wei W; Jian PE; Li SH; Guo ZX; Zhang YF; Ling YH; Lin XJ; Xu L; Shi M; Zheng L; Chen MS; Guo RP
    Cancer Commun (Lond); 2018 Oct; 38(1):61. PubMed ID: 30305149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: A propensity score matching analysis.
    Yang Y; Lin K; Liu L; Qian Y; Yang Y; Yuan S; Zhu P; Huang J; Liu F; Gu F; Fu S; Jiang B; Liu H; Pan Z; Lau WY; Zhou W
    Cancer Med; 2021 Mar; 10(6):2100-2111. PubMed ID: 33650288
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The hepatectomy efficacy of huge hepatocellular carcinoma and its risk factors: A meta analysis.
    Wang L; Liu Z; Liu X; Zeng Y; Liu J
    Medicine (Baltimore); 2017 Dec; 96(52):e9226. PubMed ID: 29384907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes of parenchymal-sparing versus anatomic resection for colorectal liver metastases: a systematic review and meta-analysis.
    Wang K; Liu Y; Hao M; Li H; Liang X; Yuan D; Ding L
    World J Surg Oncol; 2023 Aug; 21(1):241. PubMed ID: 37553574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
    Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
    [No Abstract]   [Full Text] [Related]  

  • 31. Anatomic resection and wide resection margin play an important role in hepatectomy for hepatocellular carcinoma with peritumoural micrometastasis.
    Shi C; Zhao Q; Liao B; Dong Z; Wang C; Yang J; Shen W
    ANZ J Surg; 2019 Nov; 89(11):E482-E486. PubMed ID: 31618805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complete removal of the tumor-bearing portal territory decreases local tumor recurrence and improves disease-specific survival of patients with hepatocellular carcinoma.
    Shindoh J; Makuuchi M; Matsuyama Y; Mise Y; Arita J; Sakamoto Y; Hasegawa K; Kokudo N
    J Hepatol; 2016 Mar; 64(3):594-600. PubMed ID: 26505120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.
    Zhang XP; Wang K; Wei XB; Li LQ; Sun HC; Wen TF; Chai ZT; Chen ZH; Shi J; Guo WX; Xie D; Cong WM; Wu MC; Lau WY; Cheng SQ
    Oncologist; 2019 Dec; 24(12):e1476-e1488. PubMed ID: 31138726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection.
    Chen JL; Lao XM; Lin XJ; Xu L; Cui BK; Wang J; Lin GH; Shuang ZY; Mao YZ; Huang X; Yun JP; Jin JT; Li SP
    Medicine (Baltimore); 2016 Feb; 95(5):e2665. PubMed ID: 26844496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic review of outcomes and meta-analysis of risk factors for prognosis after liver resection for hepatocellular carcinoma without cirrhosis.
    Xie QS; Chen ZX; Zhao YJ; Gu H; Geng XP; Liu FB
    Asian J Surg; 2021 Jan; 44(1):36-45. PubMed ID: 32988708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.
    Liu J; Zhu Q; Li Y; Qiao GL; Xu C; Guo DL; Tang J; Duan R
    Clin Res Hepatol Gastroenterol; 2018 Sep; 42(4):330-338. PubMed ID: 29551612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Liver transplantation vs liver resection in patients with HBV-related hepatocellular carcinoma beyond Milan criterion: A meta-analysis.
    Li W; Li L; Han J; Wu H
    Clin Transplant; 2018 Mar; 32(3):e13193. PubMed ID: 29315813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical efficacy and prognostic factors analysis following curative hepatectomy for hepatocellular carcinoma patients with different China Liver Cancer Staging].
    Li CX; Zhang H; Wu XF; Han S; Jiao CY; Wang D; Wang K; Li XC
    Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):134-143. PubMed ID: 33378806
    [No Abstract]   [Full Text] [Related]  

  • 39. Recurrence after anatomic resection versus nonanatomic resection for hepatocellular carcinoma: a meta-analysis.
    Ye JZ; Miao ZG; Wu FX; Zhao YN; Ye HH; Li LQ
    Asian Pac J Cancer Prev; 2012; 13(5):1771-7. PubMed ID: 22901120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful Anatomic Resection of Tumor-Bearing Portal Territory Delays Long-Term Stage Progression of Hepatocellular Carcinoma.
    Shindoh J; Kobayashi Y; Umino R; Kojima K; Okubo S; Hashimoto M
    Ann Surg Oncol; 2021 Feb; 28(2):844-853. PubMed ID: 32712886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.